Markets › Pakistan › KAR › GLAXO

GlaxoSmithKline Pakistan Ltd

KAR:GLAXOHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 313.98+0.49%LiveIn session · ≈ AED 4.17 · Market cap $360.61M · Next earnings Mon 26 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	20.8%	25.5%	16.5%	6.2%	23.6%	34.8%	+11.2 pts
Operating margin	9.6%	15.0%	4.5%	−6.7%	13.2%	23.7%	+10.5 pts
Net margin	9.6%	14.6%	5.9%	1.1%	10.7%	15.2%	+4.5 pts
EBITDA margin	11.7%	17.1%	6.5%	−4.8%	15.0%	25.8%	+10.7 pts
Return on equity	19.3%	25.5%	11.7%	2.5%	23.1%	29.8%	+6.7 pts
Return on assets	12.9%	17.6%	6.9%	1.4%	14.3%	19.4%	+5.1 pts
Return on capital employed	18.1%	24.9%	8.4%	−13.7%	26.2%	42.8%	+16.6 pts
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+78.0%
Debt / assets	0.2%	0.2%	0.2%	0.4%	0.4%	0.7%	+0.3 pts
Interest coverage	409.1×	693.1×	149.0×	−52.4×	88.0×	134.0×	+52.3%
Current ratio	2.0×	2.3×	1.8×	1.7×	2.1×	2.3×	+13.0%
Quick ratio	1.2×	1.4×	1.0×	0.9×	1.3×	1.4×	+13.5%
Cash ratio	0.1×	0.9×	0.3×	0.3×	0.5×	0.6×	+23.0%
Asset turnover	1.3×	1.2×	1.2×	1.3×	1.3×	1.3×	−4.5%
Inventory turnover	4.4×	3.8×	3.5×	3.8×	3.9×	3.2×	−19.2%
Receivables turnover	15.0×	12.0×	5.8×	5.8×	5.6×	5.6×	−0.6%
Dividend payout	56.0%	38.5%	15.2%	345.6%	0.0%	47.3%	+47.3 pts